Should metaxalone be held prior to induction of general anesthesia, and what is the recommended timing for discontinuation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Metaxalone Should Be Held on the Day of Surgery

Metaxalone must be discontinued on the morning of the surgical procedure prior to induction of general anesthesia 1. This is a clear, consensus-based recommendation from the Society for Perioperative Assessment and Quality Improvement (SPAQI) 2021 guidelines.

Rationale for Discontinuation

Metaxalone is a centrally acting skeletal muscle relaxant with an unclear mechanism of action that does not directly affect skeletal muscle 1, 2. The primary concerns for perioperative management include:

  • CNS depression effects: Drowsiness, dizziness, and sedation that are additive with anesthetic agents 2
  • Enhanced CNS depression when taken with food, making elderly patients especially susceptible 2
  • Potential for impaired mental and physical abilities that compound with other CNS depressants including alcohol, benzodiazepines, opioids, and anesthetic agents 2

Timing of Discontinuation

Hold metaxalone on the day of operation - meaning the morning dose should be withheld 1. The pharmacokinetics support this approach:

  • Peak plasma concentrations occur approximately 3 hours after oral administration under fasted conditions 2
  • Terminal half-life is 9.0 ± 4.8 hours under fasted conditions 2
  • The drug is extensively distributed in tissues (apparent volume of distribution ~800 L) due to its lipophilicity 2

Important Clinical Considerations

No tapering is required for metaxalone discontinuation, unlike some other centrally acting muscle relaxants (e.g., carisoprodol requires 4-9 day taper, cyclobenzaprine benefits from 2-3 week taper) 1. Metaxalone does not carry the same withdrawal risk profile.

Contraindications to be aware of:

  • Significant hepatic dysfunction (metaxalone is metabolized by the liver via multiple CYP enzymes) 1, 2
  • Significant renal dysfunction 1
  • History of drug-induced, hemolytic, or other anemias 1

Anesthetic Implications:

The sedative effects are additive with all CNS depressants used in anesthesia 2. This includes:

  • Benzodiazepines
  • Opioids
  • Propofol and other induction agents
  • Volatile anesthetics

Common Pitfall

Do not confuse metaxalone with neuromuscular blocking agents used during anesthesia. Metaxalone does not act on the neuromuscular junction or contractile mechanism of striated muscle 2. The concern is purely related to central nervous system depression and potential drug interactions with anesthetic agents, not interference with controlled neuromuscular blockade.

If a patient inadvertently takes metaxalone on the morning of surgery, the anesthesiologist should be informed to anticipate potentially enhanced CNS depression and adjust anesthetic dosing accordingly, particularly in elderly patients who are more susceptible to these effects 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.